Group | Parameter | Spearman r | hsa-miR-155-5p | hsa- miR-192-5p | hsa-miR-423-5p |
---|---|---|---|---|---|
Day 4 | |||||
 Vancomycin | Screa | rs | 0.786 | – | – |
 | P | 0.048 | – | – | |
NGAL | rs | 0.821 | – | – | |
 | P | 0.034 | – | – | |
 oATB | IL-6 | rs | – | 0.642 | – |
 | P | – | 0.003 | – | |
 all patients | NGAL | rs | 0.351 | 0.339 | 0.419 |
 | P | 0.017 | 0.021 | 0.004 | |
IL-6 | rs | 0.328 | – | – | |
 | P | 0.026 | – | – | |
Day 7 | |||||
 Vancomycin | Screa | rs | – | 0.821 | – |
 | P | – | 0.034 | – | |
NGAL | rs | – | 0.929 | – | |
 | P | – | 0.007 | – | |
PCT | rs | – | 0.847 | – | |
 | P | – | 0.025 | – | |
 oATB | PCT | rs | – | 0.558 | 0.643 |
 | P | – | 0.016 | 0.004 | |
IL-6 | rs | – | 0.598 | 0.719 | |
 | P | – | 0.009 | < 0.001 | |
 all patients | PCT | rs | 0.413 | 0.413 | 0.550 |
 | P | 0.005 | 0.005 | < 0.001 | |
IL-6 | rs | 0.357 | – | 0.491 | |
 | P | 0.017 | – | < 0.001 | |
NGAL | rs | 0.523 | – | 0,421 | |
 | P | < 0.001 | – | 0.004 | |
Screa | rs | 0.419 | – | 0.313 | |
 | P | 0.004 | – | 0.036 |